Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures

RT @CancerConnector: together with @AndriyMarusyk et al. we've extended some of these notions to cancer... and we have no reason to believe…

together with @AndriyMarusyk et al. we've extended some of these notions to cancer... and we have no reason to believe they won't generalize to any evolving system. https://t.co/6NpPib2bnd 4/n

RT @DrGEcheverria: Very cool work from the @AndriyMarusyk lab! Heterogeneity among tumor cell subpopulations in inhibitor sensitivity. Cell…

Very cool work from the @AndriyMarusyk lab! Heterogeneity among tumor cell subpopulations in inhibitor sensitivity. Cells harbor unique features and potentially therapeutic vulnerabilities during the process of developing full resistance. https://t.co/svx